Literature DB >> 2530158

A further characterization of Candida albicans-induced suppressor B-cell activity.

C F Cuff1, B J Packer, T J Rogers.   

Abstract

We have previously established that components of the organism Candida albicans are capable of inducing suppressive activity in a population of B lymphocytes. The activity of this population is antigen non-specific. The proliferative response to T-cell, but not B-cell, specific mitogens is inhibited. In addition, the antibody response in vitro is suppressed. Since little is known about this relatively unique regulatory population, we have attempted to characterize both the expression and induction of activity of the Candida-primed cells. Our results show that both primary and secondary T-cell-dependent antibody responses are inhibited, whereas both type I and type II T-cell-independent antibody responses are not affected by the suppressor cell population. T-cell populations responsible for both interleukin-2 (IL-2) and cytolytic activity are also unaffected. These results suggest that while there is no antigen specificity for this population, the suppressive activity is extended to limited target cell populations. Results also suggest that both T cells and accessory cells are required for the induction of the suppressor cell activity, indicating that the Candida organism acts as a typical T-dependent antigen in the induction of regulatory cell activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530158      PMCID: PMC1385508     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Cellular immunity in acquired candidiasis of the palate.

Authors:  E Budtz-Jörgensen
Journal:  Scand J Dent Res       Date:  1973

2.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

Review 3.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

4.  Immunosuppression induced by staphylococcal enterotoxin B.

Authors:  R P Donnelly; T J Rogers
Journal:  Cell Immunol       Date:  1982-09-01       Impact factor: 4.868

5.  Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans.

Authors:  E Piccolella; G Lombardi; R Morelli
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

6.  Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

Authors:  P Y Paterson; R Semo; G Blumenschein; J Swelstad
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

7.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

8.  Host factors in defense against fungal infections.

Authors:  C H Kirkpatrick
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis.

Authors:  S S Witkin; I R Yu; W J Ledger
Journal:  Am J Obstet Gynecol       Date:  1983-12-01       Impact factor: 8.661

10.  Mitogenic response of human peripheral blood lymphocytes to a purified C. albicans polysaccharide fraction: lack of helper activities is responsible for the in vitro unresponsiveness to a second antigenic challenge.

Authors:  E Piccolella; G Lombardi; R Morelli
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

View more
  4 in total

Review 1.  Effects of opioid tolerance and withdrawal on the immune system.

Authors:  Toby K Eisenstein; Rahil T Rahim; Pu Feng; Nita K Thingalaya; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

2.  Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages.

Authors:  T Chinen; M H Qureshi; Y Koguchi; K Kawakami
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects.

Authors:  I Quinti; C Palma; E C Guerra; M J Gomez; I Mezzaroma; F Aiuti; A Cassone
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 4.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.